Sign in

Filings

Finds words inside filing documents. Searching Liminatus Pharma, Inc.'s filings · 44 documents indexed.

13 documents · 42 matches

  1. LIMN Liminatus Pharma, Inc. 10-K 2026-03-31

    Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation.

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    6 matches in this document
  2. LIMN Liminatus Pharma, Inc. 10-Q 2026-08-14

    Item 1 · Note 1. Description of Organization and Business Operations

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    4 matches in this document
  3. LIMN Liminatus Pharma, Inc. 10-Q 2026-05-15

    Item 1 · Note 1. Description of Organization and Business Operations

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    4 matches in this document
  4. LIMN Liminatus Pharma, Inc. 10-Q 2025-11-14

    Item 1 · Note 1. Description of Organization and Business Operations

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    4 matches in this document
  5. LIMN Liminatus Pharma, Inc. 10-Q 2025-10-06

    Item 1 · Note 1. Description of Organization and Business Operations

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    4 matches in this document
  6. LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02

    Note 1. Organization and Description of Business Operations

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    3 matches in this document
  7. LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02

    going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC 205-40, Presentation of Financial Statements—Going Concern
    2 matches in this document
  8. LIMN Liminatus Pharma, Inc. 10-Q 2025-06-02

    Item 1 · Note 1. Description of Organization and Business Operations

    going concern twelve months from the issuance date of these unaudited condensed consolidated financial statements. As such, this raises substantial
    2 matches in this document
  9. LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02

    Item 2.01. Completion of Acquisition or Disposition of Assets.

    going concern within one year after the date that the accompanying financial statements are issued. The Company’s financial statements
    4 matches in this document
  10. LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02

    Note 1. Organization and Description of Business Operations

    going concern within one year after the date that the accompanying unaudited condensed financial statements are issued. The Company’s financial
    3 matches in this document
  11. LIMN Liminatus Pharma, Inc. 8-K/A 2025-06-02

    going concern within one year after the date that the accompanying unaudited condensed financial statements are issued. The Company’s financial
    4 matches in this document
  12. LIMN Liminatus Pharma, Inc. 8-K 2026-07-06

    Item 9.01. Financial Statements and Exhibits.

    going concern; performance of the Company’s and InnocsAI’s business; failure to realize the anticipated benefits of the proposed
    1 match in this document
  13. LIMN Liminatus Pharma, Inc. 8-K 2026-06-03

    going concern; performance of the Company’s business; risks relating to the Company’s sources of cash and cash resources
    1 match in this document

Page 1 of 1 · 13 documents